Algo version: 0.98b
Gemina Laboratories Ltd is listed at the PNK Exchange
Gemina Laboratories Ltd [GLABF]
PNK Sector: Healthcare Industry:Biotechnology

Is Gemina Laboratories Ltd stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Gemina Laboratories Ltd 10 years ago, but if you had invested on Tuesday 29th of March 2022 when the price was $0.420, you would have made a profit of $0.0200 per share or 4.76%

No, the average daily trading liquidity for Gemina Laboratories Ltd is $11 869 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Gemina Laboratories Ltd has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Gemina Laboratories Ltd to be high [0.9 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.